Periodonitis - acute
Methodology & AI Transparency ⓘ
Periodonitis - acute Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Physicians managing Periodonitis - acute (K05.20; Ear, Nose, Throat & Oral Health) utilize hearing protection/amplification [Periodonitis - acute K05.20] and objective Pure-Tone Audiometry & in Periodonitis - acute (K05.20: Tympanometry) targets (Thresholds <= 20 dB HL; normal middle-ear pressure (K05.20)) to prevent progression and functional morbidity.
- 2 Real-world patient consensus: Mapped to Ear, Nose, Throat & Oral Health under ICD-10-CM K05.20 for Periodonitis - acute clinical workups.
- 3 Typical cash cost range: Differential triage of Periodonitis - acute (K05.20) utilizes hearing protection/amplification [Periodonitis - acute K05.20].
- 4 Top reported side effects / signs: Longitudinal Periodonitis - acute monitoring tracks Pure-Tone Audiometry & in Periodonitis - acute (K05.20: Tympanometry) toward Thresholds <= 20 dB HL; normal middle-ear pressure (K05.20).
Ask our AI Specialists anything about Periodonitis - acute
What Is Periodonitis - acute?
Physicians managing Periodonitis - acute (K05.20; Ear, Nose, Throat & Oral Health) utilize hearing protection/amplification [Periodonitis - acute K05.20] and objective Pure-Tone Audiometry & in Periodonitis - acute (K05.20: Tympanometry) targets (Thresholds <= 20 dB HL; normal middle-ear pressure (K05.20)) to prevent progression and functional morbidity.
Pathophysiology, Underlying Causes & Clinical Presentation
In Periodonitis - acute (K05.20), physiological disruption stems from middle-ear effusion/infection [Periodonitis - acute K05.20], informing Ear, Nose, Throat & Oral Health protocols that track Periodontal Pocket Depth in Periodonitis - acute (K05.20: & Bleeding Index) (Probing <= 3 mm without bleeding (K05.20)).
Common Symptoms & Clinical Signs
- • Presentation of Periodonitis - acute (K05.20): episodic spinning vertigo in Periodonitis - acute (K05.20: accompanied by fluctuating)
- • Secondary Periodonitis - acute clinical sign: bleeding or receding in Periodonitis - acute (K05.20: gums, tooth sensitivity,)
- • Symptom flares in Periodonitis - acute correlating with Pure-Tone Audiometry & in Periodonitis - acute (K05.20: Tympanometry) deviation outside Thresholds <= 20 dB HL; normal middle-ear pressure (K05.20)
- • Functional ent & hearing impact requiring hearing protection/amplification [Periodonitis - acute K05.20] evaluation (K05.20)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Periodonitis - acute Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | K05.20 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Ear, Nose, Throat & Oral Health | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Pure-Tone Audiometry & in Periodonitis - acute (K05.20: Tympanometry) | Thresholds <= 20 dB HL; normal middle-ear pressure (K05.20) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Periodontal Pocket Depth in Periodonitis - acute (K05.20: & Bleeding Index) | Probing <= 3 mm without bleeding (K05.20) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Periodonitis - acute
Treatment selection for Periodonitis - acute depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Periodonitis - acute)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Multi-domain effectiveness of guselkumab evaluated via composite indices through: What a 285-Participant Study Found Guselkumab treatment provided substantial benefits across multiple disease domains, with increasing proportions of patients achieving LDA/full symptom relief over 1 year, highlighting the effectiveness of guselkumab despite... Rheumatology (Oxford, England) • 2025-05-01 • Phase III Randomized Trial | N = 285 | 93/100 | PMID 39437003 ↗ |
| New Insights on Bivalent RSVpreF Vaccine in Adults 18 to <60 Years Old With High-Risk: What a 453-Participant Study Found RSVpreF was well tolerated with no safety concerns and demonstrated immunobridging to efficacy in 18-59-year-olds at high risk of severe RSV disease versus ≥60-year-olds in whom efficacy was previously demonstrated, supporting... Clinical infectious diseases : an official publication of the Infectious Diseases Society of America • 2025-04-30 • Phase III Randomized Trial | N = 453 | 93/100 | PMID 39523547 ↗ |
| Can This Approach Help? Inside the Latest Research on A Post-Hoc Analysis of Emotional Lability With Delayed-Release/Extended-Release DR/ER-MPH treatment resulted in statistically significant improvements in EL to the level of non-ADHD peers as contextualized by T -scores. Journal of attention disorders • 2024-06-15 • Phase III Randomized Trial | N = 117 | 88/100 | PMID 38600754 ↗ |
Periodonitis - acute Patient Community & “People Like Me” Threads
Filter Periodonitis - acute community threads and patient logs by age, biological sex, dosage, and treatment duration.